Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1583648 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $150.19Day +5.32%Mkt cap $2.0B1Y +301.1%Off 52W high −6.9%Vol (1Y) 85.2%
Daily closing price, split-adjusted to the current basis; 1.6y shown of 395 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest15.2% of sh out |
| Days to cover9.2d |
| 13F net flow (QoQ)+15.10% |
| Top-10 13F concentration53.4% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.4M |
| Earnings (TTM)-$49.3M |
| ROE−92.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+43.5% |
| 1Y+301.1% |
| Since incept. (ann.)+357.4% |
Total return through 2026-07-30 · series begins 2024-12-16. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)85.2% |
| Ann. volatility (3Y)84.4% |
| Sharpe (1Y)2.07 |
| Sharpe (3Y)2.28 |
| Max drawdown (1Y)−31.1% |
| Max drawdown (3Y)−31.5% |
| Beta (3Y vs SPY)−2.04 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.2M | $144M | 8.06% | +29.3% |
| First Light Asset Management, LLC | 980,758 | $122M | 6.85% | +38.3% |
| BVF INC/IL | 960,989 | $120M | 6.71% | +9.3% |
| Frazier Life Sciences Management, L.P. | 882,400 | $110M | 6.16% | +22.1% |
| BlackRock, Inc. | 686,853 | $86M | 4.80% | +22.9% |
| JENNISON ASSOCIATES LLC | 640,611 | $80M | 4.48% | +65.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 477,294 | $59M | 3.33% | new |
| STATE STREET CORP | 458,999 | $57M | 3.21% | +9.2% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$1.20 | — | — | — |
| 2025-09-30 | 2025-11-10 | −$1.03 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.86 | — | — | — |
| 2025-03-31 | 2025-05-15 | −$0.74 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
